Literature DB >> 22209751

MicroRNA regulation of melanoma progression.

Vanessa F Bonazzi1, Mitchell S Stark, Nicholas K Hayward.   

Abstract

The aetiology of melanoma, the most lethal form of skin cancer, is complex, involving both genetic and environmental components. Over the past decade, many genetic alterations affecting melanoma development have been identified and more recently a new epigenetic level of regulation has increasingly been explored. MicroRNA (miRNA)-mediated epigenetic regulation of tumour suppressor genes and oncogenes has been shown to play a central role in melanomagenesis. Over the past few years, many studies combining miRNA expression arrays and quantitative reverse transcriptase-PCR assays have identified different miRNAs deregulated during melanoma progression. Several groups have focused their efforts on understanding the functional role of these different miRNAs in melanoma, identifying their direct targets and elucidating their mechanisms of regulation. This review summarizes the present knowledge of miRNA dysregulation in melanoma. On the basis of the current literature, we present a network of miRNA interactions involved in melanoma progression. Some of these key miRNAs may have utility as diagnostic markers or in targeted treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22209751     DOI: 10.1097/CMR.0b013e32834f6fbb

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  34 in total

Review 1.  Circulating epigenetic biomarkers in melanoma.

Authors:  Yu Xin; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-11

Review 2.  MicroRNAs in skin response to UV radiation.

Authors:  Deeba N Syed; Mohammad Imran Khan; Maria Shabbir; Hasan Mukhtar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

3.  Analysis of the complex interaction of CDR1as-miRNA-protein and detection of its novel role in melanoma.

Authors:  Lihuan Zhang; Yuan Li; Wenyan Liu; Huifeng Li; Zhiwei Zhu
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

Review 4.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

5.  MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene.

Authors:  Christopher Alderman; Ayoub Sehlaoui; Zhaoyang Xiao; Yixin Yang
Journal:  Tumour Biol       Date:  2016-08-04

6.  Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A.

Authors:  Hun-Way Hwang; Laura L Baxter; Stacie K Loftus; Julia C Cronin; Niraj S Trivedi; Bhavesh Borate; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-27       Impact factor: 4.693

7.  MicroRNA-103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c-Myb.

Authors:  Jinlong Liang; Xianfeng Liu; Hongpeng Xue; Bing Qiu; Bin Wei; Kan Sun
Journal:  Cell Prolif       Date:  2014-12-22       Impact factor: 6.831

Review 8.  Molecular and cellular pathogenesis of melanoma initiation and progression.

Authors:  Tarik Regad
Journal:  Cell Mol Life Sci       Date:  2013-03-27       Impact factor: 9.261

Review 9.  Control by a hair's breadth: the role of microRNAs in the skin.

Authors:  Matthew S Ning; Thomas Andl
Journal:  Cell Mol Life Sci       Date:  2012-09-15       Impact factor: 9.261

Review 10.  Long non-coding RNAs in melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Matthew Tv Chan; William Kk Wu
Journal:  Cell Prolif       Date:  2018-03-26       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.